Quick Comparison
| Sulbutiamine | Sulbutiamine | |
|---|---|---|
| Half-Life | 5 hours | 5 hours |
| Typical Dosage | Standard: 200-600 mg daily in 1-2 doses. Take with food (fat-soluble). Tolerance can develop with daily use — best cycled or used intermittently. | Standard: 200-600 mg daily in 1-2 doses. Take with food (fat-soluble). Tolerance can develop with daily use — best cycled or used intermittently. |
| Administration | Oral (capsules, tablets). Fat-soluble — take with food. | Oral (capsules, tablets). Fat-soluble — take with food. |
| Research Papers | 10 papers | 10 papers |
| Categories |
Mechanism of Action
Sulbutiamine
Sulbutiamine consists of two thiamine (vitamin B1) molecules connected by a disulfide bridge, conferring lipophilicity and efficient blood-brain barrier penetration via passive diffusion. In the brain, it is hydrolyzed to thiamine and increases thiamine diphosphate (TDP) levels—the cofactor for pyruvate dehydrogenase, alpha-ketoglutarate dehydrogenase, and transketolase, enzymes critical for glucose metabolism and the Krebs cycle. Sulbutiamine upregulates D1 dopamine receptors in the prefrontal cortex, possibly through reduced receptor internalization or increased expression. It modulates glutamatergic transmission (affecting NMDA/AMPA receptor function) and enhances cholinergic transmission. The anti-fatigue and memory-enhancing effects likely stem from improved neuronal glucose oxidation, increased ATP production, and enhanced dopaminergic and cholinergic tone in cognitive circuits.
Sulbutiamine
Sulbutiamine consists of two thiamine (vitamin B1) molecules connected by a disulfide bridge, conferring lipophilicity and efficient blood-brain barrier penetration via passive diffusion. In the brain, it is hydrolyzed to thiamine and increases thiamine diphosphate (TDP) levels—the cofactor for pyruvate dehydrogenase, alpha-ketoglutarate dehydrogenase, and transketolase, enzymes critical for glucose metabolism and the Krebs cycle. Sulbutiamine upregulates D1 dopamine receptors in the prefrontal cortex, possibly through reduced receptor internalization or increased expression. It modulates glutamatergic transmission (affecting NMDA/AMPA receptor function) and enhances cholinergic transmission. The anti-fatigue and memory-enhancing effects likely stem from improved neuronal glucose oxidation, increased ATP production, and enhanced dopaminergic and cholinergic tone in cognitive circuits.
Risks & Safety
Sulbutiamine
Common
Headache, insomnia, irritability, nausea. Tolerance develops with daily use.
Serious
No serious adverse effects documented.
Rare
Skin rash, mood instability, agitation.
Sulbutiamine
Common
Headache, insomnia, irritability, nausea. Tolerance develops with daily use.
Serious
No serious adverse effects documented.
Rare
Skin rash, mood instability, agitation.
Full Profiles
Sulbutiamine →
A synthetic fat-soluble derivative of thiamine (vitamin B1) developed in Japan to treat chronic fatigue and asthenia. Unlike regular thiamine, sulbutiamine crosses the blood-brain barrier and significantly increases thiamine levels in the brain. It modulates dopaminergic, glutamatergic, and cholinergic systems, providing mild stimulation, improved memory, and reduced mental fatigue.
Sulbutiamine →
A synthetic fat-soluble derivative of thiamine (vitamin B1) developed in Japan to treat chronic fatigue and asthenia. Unlike regular thiamine, sulbutiamine crosses the blood-brain barrier and significantly increases thiamine levels in the brain. It modulates dopaminergic, glutamatergic, and cholinergic systems, providing mild stimulation, improved memory, and reduced mental fatigue.